708 related articles for article (PubMed ID: 10224324)
1. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
2. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450: comparison of three types of expression systems.
Kranendonk M; Fisher CW; Roda R; Carreira F; Theisen P; Laires A; Rueff J; Vermeulen NP; Estabrook RW
Mutat Res; 1999 Feb; 439(2):287-300. PubMed ID: 10023085
[TBL] [Abstract][Full Text] [Related]
4. Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase.
Fujita K; Nakayama K; Yamazaki Y; Tsuruma K; Yamada M; Nohmi T; Kamataki T
Environ Mol Mutagen; 2001; 38(4):329-38. PubMed ID: 11774365
[TBL] [Abstract][Full Text] [Related]
5. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
[TBL] [Abstract][Full Text] [Related]
6. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
[TBL] [Abstract][Full Text] [Related]
7. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450-mediated biotransformation (a corrigendum report on Duarte et al. (2005) Mutagenesis 20, 93-100).
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2007 Jan; 22(1):75-81. PubMed ID: 17158518
[TBL] [Abstract][Full Text] [Related]
8. Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S. typhimurium YG7108.
Kushida H; Fujita K; Suzuki A; Yamada M; Nohmi T; Kamataki T
Mutat Res; 2000 Nov; 471(1-2):135-43. PubMed ID: 11080669
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.
Muto S; Fujita K; Yamazaki Y; Kamataki T
Mutat Res; 2001 Aug; 479(1-2):197-206. PubMed ID: 11470492
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
[TBL] [Abstract][Full Text] [Related]
11. Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1.
Yamazaki H; Hatanaka N; Kizu R; Hayakawa K; Shimada N; Guengerich FP; Nakajima M; Yokoi T
Mutat Res; 2000 Dec; 472(1-2):129-38. PubMed ID: 11113705
[TBL] [Abstract][Full Text] [Related]
12. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
[TBL] [Abstract][Full Text] [Related]
13. Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Environ Mol Mutagen; 2001; 38(4):339-46. PubMed ID: 11774366
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin.
Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T
Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470
[TBL] [Abstract][Full Text] [Related]
15. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.
Badawi AF; Cavalieri EL; Rogan EG
Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828
[TBL] [Abstract][Full Text] [Related]
16. Escherichia coli BTC, a human cytochrome P450 competent tester strain with a high sensitivity towards alkylating agents: involvement of alkyltransferases in the repair of DNA damage induced by aromatic amines.
Duarte MP; Palma BB; Laires A; Oliveira JS; Rueff J; Kranendonk M
Mutagenesis; 2005 May; 20(3):199-208. PubMed ID: 15843388
[TBL] [Abstract][Full Text] [Related]
17. Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain coexpressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial O-acetyltransferase in SOS/umu assay.
Aryal P; Terashita T; Guengerich FP; Shimada T; Oda Y
Environ Mol Mutagen; 2000; 36(2):121-6. PubMed ID: 11013410
[TBL] [Abstract][Full Text] [Related]
18. Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism.
Li DN; Pritchard MP; Hanlon SP; Burchell B; Wolf CR; Friedberg T
J Pharmacol Exp Ther; 1999 May; 289(2):661-7. PubMed ID: 10215637
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]